Evoke Pharma (EVOK) Tops Q3 EPS by 12c
Tweet
Share
E-mailGet Alerts EVOK Hot Sheet
Join SI Premium – FREE
Evoke Pharma (NASDAQ: EVOK) reported Q3 EPS of ($0.42), $0.12 better than the analyst estimate of ($0.54).
For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
- Barclays Starts Sabra Healthcare REIT Inc. (SBRA) at Equalweight
- JPMorgan Reinstates Dauch Corporation (DCH) at Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
